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Abstract: Background. Fecal incontinence (FI) is a 
common condition that has devastating consequences for 
patients’ QOL. In some patients, the conventional func-
tional pelvic floor electrical stimulation has been effective 
but is an invasive and embarrassing treatment. The object 
of the study was to evaluate the feasibility of functional 
extracorporeal magnetic stimulation (FMS) in strengthen-
ing the pelvic floor muscles without an anal plug and the 
embarrassment of undressing.   
Materials and Methods. Thirty patients (26 female and 4 
males) with FI were enrolled. All patients were assessed 
during a specialized coloproctology evaluation followed 
by endoanal ultrasonography and anorectal manometry. 
All patients underwent an FMS treatment once weekly for 
8 weeks. Patients’ outcome was assessed by the Cleveland 
Clinic Fecal Incontinence Score (CCFIS) and by the fecal 
incontinence QOL questionnaire (FIQL). 
Results. After 8 weeks, the number of solid and liquid stool 
leakage per week was significantly reduced (p<0.05) with 
a significant improvement of the CCFIS and of the FIQL 
(p<0.05). Moreover, the authors recorded a missed recruit-
ment of the agonist and antagonists’ defecation muscles.
Conclusion. FMS is a safe, non-invasive and painless 
treatment for FI. It could be recommended for selected 
patients with non-surgical FI to ensure a rapid clinical 
improvement.  
Keywords: Functional extracorporeal magnetic stimula-
tion; Fecal incontinence; Pelvic floor rehabilitation; Mag-
netic chair
1  Introduction
Fecal incontinence (FI) is defined as the involuntary loss 
of solid or liquid feces. It is a prevalent condition with 
unpleasant consequences for quality of life (QOL) [1]. FI 
can affect individuals of all ages; its overall prevalence 
in adults is calculated to be 11% to 15%, increasing with 
age QOL [2]. However, its real epidemiology appears to be 
underestimated as patients tend to avoid seeking medical 
care due to considerable embarrassment, social isolation, 
and stigma [3]. Different types of incontinence manifesta-
tions can range from unintentional elimination of flatus, 
soiling, to the complete loss of bowel contents, but in all 
cases it greatly impairs QOL. Mechanisms of continence 
involve a complex interplay between stool consistency, 
rectal compliance as reservoir, muscle groups of the pelvic 
floor, and proper function of the  anal sphincter complex. 
Alterations in any of these elements, starting from stool 
consistency to muscular proficiency, may impact conti-
nence to flatus, liquid and solid stool, and arouse FI-con-
nected symptoms. FI severity depends on the type and 
frequency of loss episodes, and of course, their role in 
modifying patients QOL. 
In selected patients, functional pelvic floor treatment 
as electrical stimulation has been reported to be effec-
tive for FI as confirmed by several randomized controlled 
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trials [4-6]. Its usefulness may be related to its unique role 
in inducing consciousness of the anal area, a feature that 
may be as useful as the stimulation itself [7-8]. In this per-
spective, increasing sensitivity in those body areas might 
help to improve the specific recruitment of anal sphinc-
ters, thereby avoiding the inappropriate recruitment of 
agonists and antagonist groups of muscles. However, 
although it is an effective technique, electric stimulation 
can be considered an invasive and embarrassing treat-
ment because of patients’ having to be undressed while 
undergoing rehabilitation and the necessity of insertion 
of an anal plug.
The aim of this study was to investigate the effective-
ness of functional extracorporeal magnetic stimulation 
(FMS) as a non-undressed and no-probe-needed alterna-
tive technique to other functional therapies in patients 
affected by idiopathic FI, as an option for functional 
pelvic floor treatment.
2  Materials and methods
2.1  Patients and methods
Consecutive patients affected by FI and referred to a 
Teaching Hospital (Division of General, Mini-Invasive 
and Obesity Surgery - Master of Coloproctology and Pelvic 
Floor Rehabilitation, University of Campania “Luigi Van-
vitelli”, Naples, Italy) between October 2018 to March 2019 
were enrolled in the study. The local ethical committee 
approved the study protocol. The study was conducted in 
accordance with the Helsinki Declaration.
All patients were informed about aims, procedures 
and follow-up; participants also signed a written informed 
consent.
Selection criteria for the study were patient’s clin-
ical history of FI for stool, liquid or flatus, and a Cleve-
land Clinic Fecal Incontinence Score (CCFIS) > 10. [9,10] 
Patients affected by urge incontinence were excluded from 
the study. The selection of patients with defecatory disor-
ders amenable for rehabilitation treatment was obtained 
using a diagnostic protocol comprising proctologic exami-
nation, clinico-physiatric assessment, muscular synergies 
and instrumental evaluation [11].
All patients were assessed during a specialized col-
oproctology evaluation in a teaching hospital. A clinical 
examination was performed on all patients and infor-
mation on bowel function, pregnancies, episiotomy, 
possible presence of pudendal nerve neuropathy, diabe-
tes, and other associated diseases were recorded. Each 
patient underwent a physical examination to evaluate 
the resting anal tone and the muscular synergy: by invit-
ing the patient to contract the anal sphincter, it was ver-
ified whether adductor (agonist muscles) or abdominal 
muscles (antagonist muscles) were contracted [11,12]. 
The CCFIS was then obtained in all patients. This scoring 
system, through 5 items (solid stool leakage, liquid stool 
leakage, gas leakage, pads use, lifestyle restriction) each 
graded from 0 to 4, allows objective evaluation of inconti-
nence severity in patients with FI [9,10]. The Fecal Incon-
tinence QOL Scale (FiQL) was submitted to all patients to 
evaluate the impact of FI on four aspects of patients’ QOL 
before the rehabilitation program and to rate the patients’ 
QOL improvement after treatment. The score consists 
of 29 questions ranging over different domains of the 
patient’s life: their lifestyle, their forced behaviour due to 
incontinence loss episodes, their personal perception of 
the disease, and finally, rating the subjective embarrass-
ment caused by FI. In detail, a lower mean value of the 
domains corresponds to a worse clinical condition [13]. A 
3D endorectal ultrasonography (3D EAUS) was performed 
before magnetic chair treatment, and a high-resolution 
anorectal manometry (HRAM) was performed both pre- 
and post-treatment.
2.2  3D Endorectal Ultrasonography (3D 
EAUS)
The device used to practice the 3D EAUS was BK Medical 
Flex Focus 800 fitted with a rotating 360° probe (model 
n.2050), covered by a cap filled with water. All the patients 
were placed in left lateral (Sims) position; the examina-
tion identified any lesion of the internal anal sphincter 
(IAS) and external anal sphincter (EAS)  [14,15]. 
2.3  High Resolution Anorectal Manometry 
(HRAM)
HRAM was performed using a solid-state probe (ManoS-
can™ AR catheter, Medtronic, Minneapolis, USA). Pres-
sure sensors were placed 1-cm apart from each other; each 
one counted 4 radially recording sensors for a total of  28 
pressure sensors. Intrarectal and intra-balloon pressures 
were recorded by two additional pressure sensors placed 
at the probe’s distal end (TactArray; Pressure Profile 
Systems, Los Angeles, California). A disposable inflatable 
balloon was located at the catheter tip. The patient was 
positioned in left lateral (Sims) position during the exam; 
the probe was then positioned in the anal canal with at 
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least one recording site in the distal rectum, and then the 
procedure was delayed a few seconds to guarantee the 
patient self-awareness of the probe’s presence. The anal 
canal length, anal resting pressures, maximum voluntary 
contraction, and rectal sensitivity were evaluated using 
Bioview Analysis software (Sandhill Sci) [16]. Evaluating 
rectal sensitivity consisted of assessing first conscious 
rectal sensation, maximum tolerate volume, and evacu-
ation stimulus, having an increasing pressured balloon 
placed in the rectum. The patients was asked to communi-
cate the volume of the balloon that caused its perception 
(first conscious rectal sensation), the one that caused the 
beginning of the evacuation stimulus, and the one that 
led to the urge need of defecation.
2.4  Design of the study
Every pelvic floor rehabilitation treatment session began 
with augmenting the patient’s awareness of the pelvic 
floor by showing them pictures of the different structures 
involved in continence to assist the patient to construct a 
proper muscles recruitment.
The device used was an armchair type magnetic stim-
ulator FMS Tesla Care® (Max Medical Sassari – Italy) 
wherein the magnetic coil was placed in the bottom of the 
chair. [Figure 1] The stimulation was provided by an elec-
tromagnetic generator in the seat, controlled by an exter-
nal unit. The intensity of the stimulation was 50–60 Hz, 
patients seated for an average time of 15 minutes on the 
chair, once weekly for 8 weeks. The magnetic field could 
be properly modified by the clinician by changing the fre-
quency and amplitude on the generator. The perineum 
needed to be in the center of the seat because the highest 
power of the magnetic field corresponded to the center of 
the chair. 
The treatment intervals were intermittent (5 seconds 
on, then 5 seconds off) to avoid muscle fatigue. The pulsed 
magnetic field generated by the device caused the con-
traction of the muscles of the pelvic floor without the need 
for an electrode. In detail, the rapid changes of the inten-
sity of the magnetic field are  generated by a phenome-
non called electromagnetic induction, which is an electric 
current in neuronal cells. The depolarization of the latter 
passes  distally to motor end plates and to the muscle 
fibers. The depolarization will also occur in sensory affer-
ent fibers and autonomic nerves that may regulate local 
blood flow and other factors. 
FMS treatment, while generating intermittent muscu-
lar contractions, increases the strength and endurance of 
the pelvic floor muscles. Additionally, the patient learns 
how to properly perform exercises that strengthen the 
muscles. 
2.5  Follow up
After the 8 weeks treatment, the patients were clinically 
scored with CCFIS and instrumentally evaluated with 
HRAM. Moreover, the FIQL questionnaire was re-submit-
ted to the patients. 
2.6  Statistical analysis 
Data were analyzed using the statistical package for 
social sciences (SPSS, version 16.0, Chicago, IL). Qualita-
tive data are expressed as percent, and quantitative data 
are expressed as the means. Statistical significance was 
defined as p<0.05 with a confidence interval (CI) at 95%.
3  Results
Thirty patients met the aforementioned inclusion criteria, 
26 females (86%) and 4 males (16%). Nine patients suf-
fered of idiopathic FI (4 males and 5 females), 21 females 
had previously given birth, and 7 of them had undergone 
episiotomy reporting a I-II degree according to Sultan clas-
sification of perineal obstetric injury [17]. Overall mean 
age was 65 (range 38–74). Seven patients were affected 
by type 2 diabetes. Patient demographics are summarized 
in Table 1. Clinical and instrumental evaluations were 
Figure 1: Tesla Care®Armchair for functional extracorporeal magne-
tic stimulation (FMS)
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appointed at the beginning of the treatment session. The 
mean CCFIS value before treatment was 12.4. The mean 
subscore values of the four domains of FiQL were, respec-
tively, lifestyle 2.6, coping 2.0, depression 3.1, and embar-
rassment 1.8. Physical examination showed incorrect syn-
ergies in 21/30 of the patients (70%), involving buttocks, 
adductors, and abdominal muscles antagonist synergies 
only in 2/21 patients (10%). All features improved by the 
treatment are summarized in Table 2. Anal manometry 
showed a mean basal pression value of 46 mmHg (min 
35 mmHg–max 65). Moreover, mean maximum volun-
tary contraction value was 110 mmHg, with an average 
duration of 14 seconds. Rectal sensibility was valued as 
30 (25–35) mL, 60 (55–70) mL, and 120 (110–130) mL. 
Endoanal ultrasound demonstrated in 7/30 (23%) patients 
a lesion of the internal anal sphincter (transversal exten-
sion 35° mean (30–40), longitudinal extension 1 cm (0.8–
1.4).  Only 3/30 (10%) patients had lesions of the internal 
sphincter (transversal extension 40° mean (35–45), longi-
tudinal extension 1.2 cm (1–1.6). None of the patients had 
concurrent lesions of internal and external sphincters. 
After treatment, a significant improvement of the 
CCIFS was recorded in 24 patients (80%). The mean CCIFS 
post-treatment value was 4.7, with a mean value reduction 
of 60% (p<0.05), its deducible clinical correlation was 
given by a statistically significant reduction of liquid and 
solid stool leakage per week. CCIFS modifications are rep-
resented in Figure 2 and Table 2.
Physical examination after treatment showed incor-
rect synergies in 3/30 of the patients (10%), involving but-
tocks and adductors, whereas abdominal muscles were 
stimulated in none of the patients. [Table 2]
FiQL domains scores improved in 27 out of 30 patients 
(90%). Post-treatment FiQL scores were 3.2, 2.7, 3.6, and 2.4 
Table 1: Patients demographics features. Values are expressed as 
number of cases or mean (*). FI (Fecal Incontinence)
Patients group (n=30)
Age 65* (51-69)
Gender 26 females (86,7%)
4 males (13,3%)






Comorbidities 7 (type II diabetes) (23,3%)
Table 2: Pre and post treatment clinical and instrumental parameters. Values are expressed as mean or number of cases (*). FMS (functional 
extracorporeal magnetic stimulation); CCSFIS (Cleveland Clinic Faecal Incontinence Score); FiQL (Fecal Incontinence Quality of Life Scale); 
HRAM (High Resolution Anorectal Manometry) 
Item Before FMS After FMS p


















Buttocks/adductor synergies 21/30* 3/30* <0.05
Abdominal synergies 2/30* 0/30* NS
HRAM
- basal pression











Figure 2: Modifications of the CCSFIS before and after FMS treatment
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regarding lifestyle, coping, depression, and embarrass-
ment patterns respectively. FiQL modifications are shown 
in Figure 3 and Table 3 showed the number of patients 
improved after FMS according to the clinical items.
No statistically changes were recorded in anal manom-
etry after the eight weeks’ treatment time. In fact, the 
mean basal pression value was 48 mmHg (36–68 mmHg) 
and the mean maximum voluntary contraction value was 
114 mmHg with an average duration of 15 seconds (p=NS) 
[Table 2] [Fig 4].
4  Discussion
Fecal incontinence is a multifactorial disease. Different 
mechanisms of continence are involved in the retention of 
gas and stools. Loss of continence can result from solitary 
anatomic defects, or more often, from alterations such as 
lesions or sphincters either caused by deliveries [18,19].
Hence, fecal incontinence  is not only a diagnosis 
but a frequent and debilitating common final pathway 
symptom resulting from numerous different causes, 
regarding muscles competence, proper innervation, and 
the complex functioning of all these structures as a unit. 
That is, pelvic floor rehabilitation, having a primary target 
to recreate harmony among all the pelvic floor structures 
rather than curing symptoms, clearly has its important 
role in improving FI. The first step is to induce awareness 
of the pelvic floor muscles areas; the role of these areas 
in determining rehabilitation usefulness has exhaustively 
been studied [7]. 
Among other rehabilitation treatment techniques, 
anal electrostimulation is presently routinely performed 
and known as an effective nonoperative treatment for FI. 
It’s also been speculated that aside from the mere electric 
stimulation, this technique might owe its curative role to 
its ability to arouse the patient’s consciousness of the anal 
canal based on the fact that the sole knowledge of certain 
parts of the body better allows their selective recruitment 
[7]. Besides its usefulness, the extremely low compliance 
of patients to electrostimulation has also been assessed 
[20]. As a matter of fact, patients need to be undressed 
and experience the insertion of an anal plug; both details 
that strongly determine patients embarrassment and dis-
comfort leading to the avoidance of this treatment. There-
fore, the FMS is a relatively new technique that combines 
electrostimulation’s usefulness to a higher compliance. 
FMS represents a novel application of a classic princi-
ple of physics: a flow of electrons within the field will be 
induced by a changing magnetic field. The pulsing of the 
magnetic field precisely induces small currents to flow in 
the tissue that has the role of inducing depolarization of 
nerve axons, leading in turn to a nerve impulse travelling 
both in proximal and distal directions. The subsequent 
relapse of acetylcholine will result in the depolarization 
and contraction of the corresponding muscle fibers; the 
key to the efficacy of FMS is the depolarization of nerve 
fibers as it induces the strengthening of the muscles. FMS 
clinical effect is changing the activity of muscle groups 
in the pelvic floor. The repeated activation of a muscle’s 
activity caused by its nerves depolarization builds muscle 
strength and endurance. FMS is painless, and no electric-
ity passes through the body, only a magnetic flux. More-
over, in functional electrical stimulation, a greater elec-
trical current is needed to modulate the nerves because 
Figure 3: Modifications of the four domains of FiQL after FMS
Table 3: FI clinical items improvements. Values expressed as number of cases and percentage. FI (fecal Incontinence) FMS (functional extra-
corporeal magnetic stimulation); CCSFIS (Cleveland Clinic Faecal Incontinence Score); FiQL (Fecal Incontinence Quality of Life Scale); 
Item Patients improved after FMS Percentage 
CCSFIS 24/30 80%
FiQL 27/30 90%
Buttocks/adductor synergies 21/30 70%
Abdominal synergies 30/30 100%
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of the high impedance of the tissues and bones than 
demanded by FMS [21].
Different studies have assessed FMS effectiveness 
in urinary incontinence [22]. Yamanishi et al  examined 
the effects of magnetic stimulation as well; they studied 
how FMS augmented urethral closure in healthy volun-
teers. During pelvic floor stimulation, they demonstrated 
and recorded significant increases in maximum urethral 
closure pressures [23]. These above-mentioned principles 
studied in urinary incontinence are applicable also to 
fecal incontinence, although literature examining them 
is still meager. To the best of our knowledge, the current 
study is the first reporting the effectiveness and feasibility 
of FMS in the treatment of FI.  
The present study included patients with idiopathic 
FI. In comparison with the baseline value, a statically sig-
nificant improvement in CCFIS score was recorded: it was 
found to be decreased after the treatment period, with a 
mean value reduction of 60%, and an absolute mean 
value of 4.7. FMS clearly improved gas, liquid, solid stool 
leakage, and improved the satisfaction of all patients in 
our cohort, according to a statistically significant increase 
of all the four domains of FiQL values (p>0.05). This result 
attests the decrease of psychological distress related to 
the patients’ clinical condition as well as a reduction of 
the forced everyday life changes imposed by the pathol-
ogy. In our series we did not observe a significant improve 
in of basal pressure, maximum voluntary contraction, 
and duration of contraction at HRAM. This is apparently 
in contrast with the clinical parameters improvements 
recorded in our cohort. Most likely, the clinical symp-
toms relief is associated to a better recruitment of antago-
nist and agonist muscles, to the increase of strength and 
endurance of the pelvic floor muscles, and to the aware-
ness of the pelvic floor itself acquired by the patients.   
Therefore, compared to anal electrostimulation, FMS 
increases major patient compliance as it is painless, not 
invasive, and does not requiring undressing. FMS creates 
neural stimulation which can penetrate into all kinds 
of tissue with no attenuation; therefore, intensity of the 
energy is lower than anal electrostimulation, drastically 
reducing pain. Given lack of invasiveness, FMS might be 
particularly suitable for children as well, even if there a 
lack of results in literature remains. On the other hand, 
other kinds of conventional electro stimulations have 
been studied in children affected by pediatric voiding dys-
function, which have proved effective but uncomfortable. 
Undressing for attaching electrodes at every stimulation 
session can, in fact, make children nervous and noncom-
pliant, and the required electrical stimuli for actual neural 
stimulation causes more pain and discomfort in children 
than in adults [24]. Yokoyama et al reported that frequen-
cies of 20 to 50 Hz were effective for stress urinary incon-
tinence and significantly increased the maximal intraure-
thral pressure [6]. Presently, no study reports the optimal 
pulse duration and frequency of FMS in FI. In our series, 
we adopted a frequency of 50–60 Hz for 15 minutes on the 
chair, once a week, for 8 weeks. A drawback of the FMS 
Figure 4: Pre FMS treatment (a) and post FSM treatment (b) HRAM (High Resolution Anal Manometry) showing no significant sphincteral 
improvement
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treatment is certainly the cost. FMS, in fact, is an expen-
sive method with the chair cost that is about 40.000 € [21]. 
Contrary to most authors [6,21,24], Voorham et al in their 
study of 74 patients affected by urinary incontinence, 
reported no differences in pelvic floor muscle activity, 
pad-test, QoL, voiding diary, and urodynamics in patients 
treated with FMS. Those authors underlined the impor-
tance of patient  selection and concluded that  ‘the chair’ 
is suitable to train awareness of the location of the pelvic 
floor, but the need for active pelvic floor muscle exercises 
remains [4].
The present study has some limitations. First is the 
small sample size, which precluded any analysis of the 
effect of covariates. In addition, the real question of neu-
romodulation is the long-term recurrence of symptoms 
when the neural stimulation treatment stops [25,26]. We 
do not yet have long‐term follow‐up data after stimula-
tion, as the present study was prospective and focused 
on assessing FMS effectiveness and feasibility. Moreover, 
different programs of stimulation can be used by the phy-
sician to increase effectiveness and likely to reduce recur-
rence of the symptoms; thus studies on the appropriate 
duration of stimulation, combined treatments, and rand-
omized controlled studies with a sham‐stimulation group 
are needed. 
5  Conclusions
FMS of the pelvic floor is an effective treatment for idio-
pathic fecal incontinence, resulting in patients improved 
QOL and decrease of incontinence scores, comparable 
to conventional anal electrostimulation. Extracorpor-
eal magnetic stimulation is a comfortable technique as 
it avoids patient embarrassment through no need to get 
undressed; it also eliminates the discomfort and inva-
siveness related to the anal probe. Further long-term and 
comparative studies are needed to investigate the efficacy 
of the treatment in a large population with pelvic floor dis-
orders.   
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